Employer record no. 23088
Modalis Therapeutics Inc.
US DOL LCA disclosure data, FY2020 to FY2026
Total LCA filings
13
Certified
7
Denied
0
FY2025 filings
1
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#2,108 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 1 | 1 | 0 | $67,956 | $67,954 |
| FY2022 | 4 | 3 | 0 | $149,229 | $109,637 |
| FY2023 | 3 | 1 | 0 | $78,805 | $77,654 |
| FY2024 | 3 | 0 | 0 | $129,486 | $102,745 |
| FY2025 | 1 | 1 | 0 | $85,842 | $85,842 |
| FY2026 * | 1 | 1 | 0 | $78,000 | $77,501 |
What they file for
- research associate$76,5127
- director, translational research$220,0003
- research associate ii$90,0002
- senior research associate$78,0001
Where
- waltham, ma9
- cambridge, ma2
- queens, ny2
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Modalis Therapeutics Inc. and any other employer they watch.
Certification rate 53.8%How these numbers are computed